For weight management, other FDA-approved medications exist, including phentermine-topiramate and naltrexone-bupropion combinations
Cardiovascular Protection and Risk Reduction Obesity and diabetes substantially elevate cardiovascular disease risk through multiple mechanisms including atherosclerosis, endothelial dysfunction, inflammation, and hemodynamic stress
The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award
Ipamorelin can still be timed nocturnally for acute pulses, but the CJC component no longer requires circadian alignment
Selected Publications White MA, Martin PD, Newton RL, Walden HM, York-Crowe EE, Gordon ST, Ryan DH, Williamson DA
Most people notice a significant decrease in appetite within the first few weeks of treatment, making it much easier to stick to healthy eating habits without feeling deprived